Scientific Reports-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2180350, encodeId=2c3c2180350d7, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：1 Reviewer report received 4个月了有没有大佬知道邮箱是多少想催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78df8786027, createdName=ms9000000778917018, createdTime=Tue Jan 09 21:07:33 CST 2024, time=2024-01-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2179786, encodeId=39de21e9786b5, content=👍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99f91357734, createdName=connie19860928, createdTime=Sun Jan 07 12:06:10 CST 2024, time=2024-01-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178835, encodeId=7a4321e883536, content=医学生信类这刊送外审了，被拒率高吗，有没有大佬了解的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:32:31 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2136242, encodeId=ff8f213624228, content=之前状态有过2 reviewers accepted，10天后变成1 reviewer report received状态后，现在已经持续快一个月了，有没有大佬知道后续还要等多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e41e8578522, createdName=ms2000000826223232, createdTime=Wed May 17 00:23:11 CST 2023, time=2023-05-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2122705, encodeId=69722122e051a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：药理学 经验分享：12月20号初投 12月28号修改格式再投 12月29号外审 1月23号意见返回小修 2月2号修回 2月7号二审 3月27号发了邮件催了一下28号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5196569930, createdName=ms4000001456586006, createdTime=Thu Mar 30 12:35:58 CST 2023, time=2023-03-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2167125, encodeId=1569216e12553, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：大神们啊，我的修改提交后收到一份修改意见后，就一直不动了，已经一个多月了，应该怎么办啊，是不是被遗忘了啊，家人们求解啊，该怎么办好啊，在线等哦 Peer review 1 Reviewer report received 05 Oct 23 Submission under peer review 19 Sep 2023 Submission passed technical check 19 Sep 2023 Revision received 17 Sep 2023 Submission under peer review 31 May 2023 Technical check Submission status Date Submission passed technical check 31 May 2023 Amendment received 22 May 2023 Amendment received 17 May 2023 Submission is under technical check 12 May 2023 Submission received Submission status Date Submission received 12 May 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a358285446, createdName=ms6000002137455091, createdTime=Tue Nov 07 00:30:06 CST 2023, time=2023-11-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176057, encodeId=9bad21e60571f, content=editor invited 到底要多久呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a73b2470790, createdName=Good luck3604, createdTime=Wed Dec 20 10:27:08 CST 2023, time=2023-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2176528, encodeId=a2de21e652869, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：投稿到接收6个月一共6个编辑 2个接收 4个给了小修意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56409118645, createdName=ms4000001399005501, createdTime=Fri Dec 22 13:59:13 CST 2023, time=2023-12-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2175766, encodeId=4b6021e57663e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：您好！ 请加一下**，复旦大学工作，希望和您深入沟通，谢谢您！ 17768300857, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd5a9105529, createdName=ms9000001835062032, createdTime=Tue Dec 19 10:43:11 CST 2023, time=2023-12-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2174747, encodeId=a33621e4747f9, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：23.05.23投稿 23.08.21两个审稿人接收 23.09.16大修 23.09.29修改后投稿 23.10.12一个审稿人同意发表，另一个审稿人要求小修 23.10.25二修后再投 23.11.07accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=550b8770319, createdName=ms8000001177361067, createdTime=Wed Dec 13 16:06:30 CST 2023, time=2023-12-13, status=1, ipAttribution=重庆)]

2024-01-09 ms9000000778917018 来自山东省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：生信
经验分享：1 Reviewer report received 4个月了有没有大佬知道邮箱是多少想催稿了

30 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2180350, encodeId=2c3c2180350d7, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：1 Reviewer report received 4个月了有没有大佬知道邮箱是多少想催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78df8786027, createdName=ms9000000778917018, createdTime=Tue Jan 09 21:07:33 CST 2024, time=2024-01-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2179786, encodeId=39de21e9786b5, content=👍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99f91357734, createdName=connie19860928, createdTime=Sun Jan 07 12:06:10 CST 2024, time=2024-01-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178835, encodeId=7a4321e883536, content=医学生信类这刊送外审了，被拒率高吗，有没有大佬了解的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:32:31 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2136242, encodeId=ff8f213624228, content=之前状态有过2 reviewers accepted，10天后变成1 reviewer report received状态后，现在已经持续快一个月了，有没有大佬知道后续还要等多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e41e8578522, createdName=ms2000000826223232, createdTime=Wed May 17 00:23:11 CST 2023, time=2023-05-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2122705, encodeId=69722122e051a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：药理学 经验分享：12月20号初投 12月28号修改格式再投 12月29号外审 1月23号意见返回小修 2月2号修回 2月7号二审 3月27号发了邮件催了一下28号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5196569930, createdName=ms4000001456586006, createdTime=Thu Mar 30 12:35:58 CST 2023, time=2023-03-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2167125, encodeId=1569216e12553, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：大神们啊，我的修改提交后收到一份修改意见后，就一直不动了，已经一个多月了，应该怎么办啊，是不是被遗忘了啊，家人们求解啊，该怎么办好啊，在线等哦 Peer review 1 Reviewer report received 05 Oct 23 Submission under peer review 19 Sep 2023 Submission passed technical check 19 Sep 2023 Revision received 17 Sep 2023 Submission under peer review 31 May 2023 Technical check Submission status Date Submission passed technical check 31 May 2023 Amendment received 22 May 2023 Amendment received 17 May 2023 Submission is under technical check 12 May 2023 Submission received Submission status Date Submission received 12 May 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a358285446, createdName=ms6000002137455091, createdTime=Tue Nov 07 00:30:06 CST 2023, time=2023-11-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176057, encodeId=9bad21e60571f, content=editor invited 到底要多久呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a73b2470790, createdName=Good luck3604, createdTime=Wed Dec 20 10:27:08 CST 2023, time=2023-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2176528, encodeId=a2de21e652869, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：投稿到接收6个月一共6个编辑 2个接收 4个给了小修意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56409118645, createdName=ms4000001399005501, createdTime=Fri Dec 22 13:59:13 CST 2023, time=2023-12-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2175766, encodeId=4b6021e57663e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：您好！ 请加一下**，复旦大学工作，希望和您深入沟通，谢谢您！ 17768300857, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd5a9105529, createdName=ms9000001835062032, createdTime=Tue Dec 19 10:43:11 CST 2023, time=2023-12-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2174747, encodeId=a33621e4747f9, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：23.05.23投稿 23.08.21两个审稿人接收 23.09.16大修 23.09.29修改后投稿 23.10.12一个审稿人同意发表，另一个审稿人要求小修 23.10.25二修后再投 23.11.07accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=550b8770319, createdName=ms8000001177361067, createdTime=Wed Dec 13 16:06:30 CST 2023, time=2023-12-13, status=1, ipAttribution=重庆)]

2024-01-07 connie19860928 来自四川省

👍

20 0

[GetPortalCommentsPageByObjectIdResponse(id=2180350, encodeId=2c3c2180350d7, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：1 Reviewer report received 4个月了有没有大佬知道邮箱是多少想催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78df8786027, createdName=ms9000000778917018, createdTime=Tue Jan 09 21:07:33 CST 2024, time=2024-01-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2179786, encodeId=39de21e9786b5, content=👍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99f91357734, createdName=connie19860928, createdTime=Sun Jan 07 12:06:10 CST 2024, time=2024-01-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178835, encodeId=7a4321e883536, content=医学生信类这刊送外审了，被拒率高吗，有没有大佬了解的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:32:31 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2136242, encodeId=ff8f213624228, content=之前状态有过2 reviewers accepted，10天后变成1 reviewer report received状态后，现在已经持续快一个月了，有没有大佬知道后续还要等多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e41e8578522, createdName=ms2000000826223232, createdTime=Wed May 17 00:23:11 CST 2023, time=2023-05-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2122705, encodeId=69722122e051a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：药理学 经验分享：12月20号初投 12月28号修改格式再投 12月29号外审 1月23号意见返回小修 2月2号修回 2月7号二审 3月27号发了邮件催了一下28号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5196569930, createdName=ms4000001456586006, createdTime=Thu Mar 30 12:35:58 CST 2023, time=2023-03-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2167125, encodeId=1569216e12553, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：大神们啊，我的修改提交后收到一份修改意见后，就一直不动了，已经一个多月了，应该怎么办啊，是不是被遗忘了啊，家人们求解啊，该怎么办好啊，在线等哦 Peer review 1 Reviewer report received 05 Oct 23 Submission under peer review 19 Sep 2023 Submission passed technical check 19 Sep 2023 Revision received 17 Sep 2023 Submission under peer review 31 May 2023 Technical check Submission status Date Submission passed technical check 31 May 2023 Amendment received 22 May 2023 Amendment received 17 May 2023 Submission is under technical check 12 May 2023 Submission received Submission status Date Submission received 12 May 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a358285446, createdName=ms6000002137455091, createdTime=Tue Nov 07 00:30:06 CST 2023, time=2023-11-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176057, encodeId=9bad21e60571f, content=editor invited 到底要多久呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a73b2470790, createdName=Good luck3604, createdTime=Wed Dec 20 10:27:08 CST 2023, time=2023-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2176528, encodeId=a2de21e652869, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：投稿到接收6个月一共6个编辑 2个接收 4个给了小修意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56409118645, createdName=ms4000001399005501, createdTime=Fri Dec 22 13:59:13 CST 2023, time=2023-12-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2175766, encodeId=4b6021e57663e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：您好！ 请加一下**，复旦大学工作，希望和您深入沟通，谢谢您！ 17768300857, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd5a9105529, createdName=ms9000001835062032, createdTime=Tue Dec 19 10:43:11 CST 2023, time=2023-12-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2174747, encodeId=a33621e4747f9, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：23.05.23投稿 23.08.21两个审稿人接收 23.09.16大修 23.09.29修改后投稿 23.10.12一个审稿人同意发表，另一个审稿人要求小修 23.10.25二修后再投 23.11.07accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=550b8770319, createdName=ms8000001177361067, createdTime=Wed Dec 13 16:06:30 CST 2023, time=2023-12-13, status=1, ipAttribution=重庆)]

2024-01-02 Dehors 来自江苏省

医学生信类这刊送外审了，被拒率高吗，有没有大佬了解的

32 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2180350, encodeId=2c3c2180350d7, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：1 Reviewer report received 4个月了有没有大佬知道邮箱是多少想催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78df8786027, createdName=ms9000000778917018, createdTime=Tue Jan 09 21:07:33 CST 2024, time=2024-01-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2179786, encodeId=39de21e9786b5, content=👍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99f91357734, createdName=connie19860928, createdTime=Sun Jan 07 12:06:10 CST 2024, time=2024-01-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178835, encodeId=7a4321e883536, content=医学生信类这刊送外审了，被拒率高吗，有没有大佬了解的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:32:31 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2136242, encodeId=ff8f213624228, content=之前状态有过2 reviewers accepted，10天后变成1 reviewer report received状态后，现在已经持续快一个月了，有没有大佬知道后续还要等多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e41e8578522, createdName=ms2000000826223232, createdTime=Wed May 17 00:23:11 CST 2023, time=2023-05-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2122705, encodeId=69722122e051a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：药理学 经验分享：12月20号初投 12月28号修改格式再投 12月29号外审 1月23号意见返回小修 2月2号修回 2月7号二审 3月27号发了邮件催了一下28号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5196569930, createdName=ms4000001456586006, createdTime=Thu Mar 30 12:35:58 CST 2023, time=2023-03-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2167125, encodeId=1569216e12553, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：大神们啊，我的修改提交后收到一份修改意见后，就一直不动了，已经一个多月了，应该怎么办啊，是不是被遗忘了啊，家人们求解啊，该怎么办好啊，在线等哦 Peer review 1 Reviewer report received 05 Oct 23 Submission under peer review 19 Sep 2023 Submission passed technical check 19 Sep 2023 Revision received 17 Sep 2023 Submission under peer review 31 May 2023 Technical check Submission status Date Submission passed technical check 31 May 2023 Amendment received 22 May 2023 Amendment received 17 May 2023 Submission is under technical check 12 May 2023 Submission received Submission status Date Submission received 12 May 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a358285446, createdName=ms6000002137455091, createdTime=Tue Nov 07 00:30:06 CST 2023, time=2023-11-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176057, encodeId=9bad21e60571f, content=editor invited 到底要多久呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a73b2470790, createdName=Good luck3604, createdTime=Wed Dec 20 10:27:08 CST 2023, time=2023-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2176528, encodeId=a2de21e652869, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：投稿到接收6个月一共6个编辑 2个接收 4个给了小修意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56409118645, createdName=ms4000001399005501, createdTime=Fri Dec 22 13:59:13 CST 2023, time=2023-12-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2175766, encodeId=4b6021e57663e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：您好！ 请加一下**，复旦大学工作，希望和您深入沟通，谢谢您！ 17768300857, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd5a9105529, createdName=ms9000001835062032, createdTime=Tue Dec 19 10:43:11 CST 2023, time=2023-12-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2174747, encodeId=a33621e4747f9, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：23.05.23投稿 23.08.21两个审稿人接收 23.09.16大修 23.09.29修改后投稿 23.10.12一个审稿人同意发表，另一个审稿人要求小修 23.10.25二修后再投 23.11.07accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=550b8770319, createdName=ms8000001177361067, createdTime=Wed Dec 13 16:06:30 CST 2023, time=2023-12-13, status=1, ipAttribution=重庆)]

2023-05-17 ms2000000826223232 来自浙江省

之前状态有过2 reviewers accepted，10天后变成1 reviewer report received状态后，现在已经持续快一个月了，有没有大佬知道后续还要等多久呀？

48 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2180350, encodeId=2c3c2180350d7, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：1 Reviewer report received 4个月了有没有大佬知道邮箱是多少想催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78df8786027, createdName=ms9000000778917018, createdTime=Tue Jan 09 21:07:33 CST 2024, time=2024-01-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2179786, encodeId=39de21e9786b5, content=👍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99f91357734, createdName=connie19860928, createdTime=Sun Jan 07 12:06:10 CST 2024, time=2024-01-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178835, encodeId=7a4321e883536, content=医学生信类这刊送外审了，被拒率高吗，有没有大佬了解的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:32:31 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2136242, encodeId=ff8f213624228, content=之前状态有过2 reviewers accepted，10天后变成1 reviewer report received状态后，现在已经持续快一个月了，有没有大佬知道后续还要等多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e41e8578522, createdName=ms2000000826223232, createdTime=Wed May 17 00:23:11 CST 2023, time=2023-05-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2122705, encodeId=69722122e051a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：药理学 经验分享：12月20号初投 12月28号修改格式再投 12月29号外审 1月23号意见返回小修 2月2号修回 2月7号二审 3月27号发了邮件催了一下28号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5196569930, createdName=ms4000001456586006, createdTime=Thu Mar 30 12:35:58 CST 2023, time=2023-03-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2167125, encodeId=1569216e12553, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：大神们啊，我的修改提交后收到一份修改意见后，就一直不动了，已经一个多月了，应该怎么办啊，是不是被遗忘了啊，家人们求解啊，该怎么办好啊，在线等哦 Peer review 1 Reviewer report received 05 Oct 23 Submission under peer review 19 Sep 2023 Submission passed technical check 19 Sep 2023 Revision received 17 Sep 2023 Submission under peer review 31 May 2023 Technical check Submission status Date Submission passed technical check 31 May 2023 Amendment received 22 May 2023 Amendment received 17 May 2023 Submission is under technical check 12 May 2023 Submission received Submission status Date Submission received 12 May 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a358285446, createdName=ms6000002137455091, createdTime=Tue Nov 07 00:30:06 CST 2023, time=2023-11-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176057, encodeId=9bad21e60571f, content=editor invited 到底要多久呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a73b2470790, createdName=Good luck3604, createdTime=Wed Dec 20 10:27:08 CST 2023, time=2023-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2176528, encodeId=a2de21e652869, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：投稿到接收6个月一共6个编辑 2个接收 4个给了小修意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56409118645, createdName=ms4000001399005501, createdTime=Fri Dec 22 13:59:13 CST 2023, time=2023-12-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2175766, encodeId=4b6021e57663e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：您好！ 请加一下**，复旦大学工作，希望和您深入沟通，谢谢您！ 17768300857, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd5a9105529, createdName=ms9000001835062032, createdTime=Tue Dec 19 10:43:11 CST 2023, time=2023-12-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2174747, encodeId=a33621e4747f9, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：23.05.23投稿 23.08.21两个审稿人接收 23.09.16大修 23.09.29修改后投稿 23.10.12一个审稿人同意发表，另一个审稿人要求小修 23.10.25二修后再投 23.11.07accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=550b8770319, createdName=ms8000001177361067, createdTime=Wed Dec 13 16:06:30 CST 2023, time=2023-12-13, status=1, ipAttribution=重庆)]

2023-03-30 ms4000001456586006 来自上海

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：药理学
经验分享：12月20号初投
12月28号修改格式再投
12月29号外审
1月23号意见返回小修
2月2号修回
2月7号二审
3月27号发了邮件催了一下28号接受

158 15

展开15条回复

[GetPortalCommentsPageByObjectIdResponse(id=2180350, encodeId=2c3c2180350d7, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：1 Reviewer report received 4个月了有没有大佬知道邮箱是多少想催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78df8786027, createdName=ms9000000778917018, createdTime=Tue Jan 09 21:07:33 CST 2024, time=2024-01-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2179786, encodeId=39de21e9786b5, content=👍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99f91357734, createdName=connie19860928, createdTime=Sun Jan 07 12:06:10 CST 2024, time=2024-01-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178835, encodeId=7a4321e883536, content=医学生信类这刊送外审了，被拒率高吗，有没有大佬了解的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:32:31 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2136242, encodeId=ff8f213624228, content=之前状态有过2 reviewers accepted，10天后变成1 reviewer report received状态后，现在已经持续快一个月了，有没有大佬知道后续还要等多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e41e8578522, createdName=ms2000000826223232, createdTime=Wed May 17 00:23:11 CST 2023, time=2023-05-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2122705, encodeId=69722122e051a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：药理学 经验分享：12月20号初投 12月28号修改格式再投 12月29号外审 1月23号意见返回小修 2月2号修回 2月7号二审 3月27号发了邮件催了一下28号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5196569930, createdName=ms4000001456586006, createdTime=Thu Mar 30 12:35:58 CST 2023, time=2023-03-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2167125, encodeId=1569216e12553, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：大神们啊，我的修改提交后收到一份修改意见后，就一直不动了，已经一个多月了，应该怎么办啊，是不是被遗忘了啊，家人们求解啊，该怎么办好啊，在线等哦 Peer review 1 Reviewer report received 05 Oct 23 Submission under peer review 19 Sep 2023 Submission passed technical check 19 Sep 2023 Revision received 17 Sep 2023 Submission under peer review 31 May 2023 Technical check Submission status Date Submission passed technical check 31 May 2023 Amendment received 22 May 2023 Amendment received 17 May 2023 Submission is under technical check 12 May 2023 Submission received Submission status Date Submission received 12 May 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a358285446, createdName=ms6000002137455091, createdTime=Tue Nov 07 00:30:06 CST 2023, time=2023-11-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176057, encodeId=9bad21e60571f, content=editor invited 到底要多久呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a73b2470790, createdName=Good luck3604, createdTime=Wed Dec 20 10:27:08 CST 2023, time=2023-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2176528, encodeId=a2de21e652869, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：投稿到接收6个月一共6个编辑 2个接收 4个给了小修意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56409118645, createdName=ms4000001399005501, createdTime=Fri Dec 22 13:59:13 CST 2023, time=2023-12-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2175766, encodeId=4b6021e57663e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：您好！ 请加一下**，复旦大学工作，希望和您深入沟通，谢谢您！ 17768300857, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd5a9105529, createdName=ms9000001835062032, createdTime=Tue Dec 19 10:43:11 CST 2023, time=2023-12-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2174747, encodeId=a33621e4747f9, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：23.05.23投稿 23.08.21两个审稿人接收 23.09.16大修 23.09.29修改后投稿 23.10.12一个审稿人同意发表，另一个审稿人要求小修 23.10.25二修后再投 23.11.07accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=550b8770319, createdName=ms8000001177361067, createdTime=Wed Dec 13 16:06:30 CST 2023, time=2023-12-13, status=1, ipAttribution=重庆)]

2023-11-07 ms6000002137455091 来自浙江省

审稿速度:12.0 | 投稿命中率:25.0
经验分享：大神们啊，我的修改提交后收到一份修改意见后，就一直不动了，已经一个多月了，应该怎么办啊，是不是被遗忘了啊，家人们求解啊，该怎么办好啊，在线等哦
Peer review
1 Reviewer report received 05 Oct 23
Submission under peer review
19 Sep 2023
Submission passed technical check
19 Sep 2023
Revision received
17 Sep 2023
Submission under peer review
31 May 2023
Technical check
Submission status Date
Submission passed technical check
31 May 2023
Amendment received
22 May 2023
Amendment received
17 May 2023
Submission is under technical check
12 May 2023
Submission received
Submission status Date
Submission received
12 May 2023

48 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2180350, encodeId=2c3c2180350d7, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：1 Reviewer report received 4个月了有没有大佬知道邮箱是多少想催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78df8786027, createdName=ms9000000778917018, createdTime=Tue Jan 09 21:07:33 CST 2024, time=2024-01-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2179786, encodeId=39de21e9786b5, content=👍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99f91357734, createdName=connie19860928, createdTime=Sun Jan 07 12:06:10 CST 2024, time=2024-01-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178835, encodeId=7a4321e883536, content=医学生信类这刊送外审了，被拒率高吗，有没有大佬了解的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:32:31 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2136242, encodeId=ff8f213624228, content=之前状态有过2 reviewers accepted，10天后变成1 reviewer report received状态后，现在已经持续快一个月了，有没有大佬知道后续还要等多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e41e8578522, createdName=ms2000000826223232, createdTime=Wed May 17 00:23:11 CST 2023, time=2023-05-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2122705, encodeId=69722122e051a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：药理学 经验分享：12月20号初投 12月28号修改格式再投 12月29号外审 1月23号意见返回小修 2月2号修回 2月7号二审 3月27号发了邮件催了一下28号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5196569930, createdName=ms4000001456586006, createdTime=Thu Mar 30 12:35:58 CST 2023, time=2023-03-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2167125, encodeId=1569216e12553, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：大神们啊，我的修改提交后收到一份修改意见后，就一直不动了，已经一个多月了，应该怎么办啊，是不是被遗忘了啊，家人们求解啊，该怎么办好啊，在线等哦 Peer review 1 Reviewer report received 05 Oct 23 Submission under peer review 19 Sep 2023 Submission passed technical check 19 Sep 2023 Revision received 17 Sep 2023 Submission under peer review 31 May 2023 Technical check Submission status Date Submission passed technical check 31 May 2023 Amendment received 22 May 2023 Amendment received 17 May 2023 Submission is under technical check 12 May 2023 Submission received Submission status Date Submission received 12 May 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a358285446, createdName=ms6000002137455091, createdTime=Tue Nov 07 00:30:06 CST 2023, time=2023-11-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176057, encodeId=9bad21e60571f, content=editor invited 到底要多久呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a73b2470790, createdName=Good luck3604, createdTime=Wed Dec 20 10:27:08 CST 2023, time=2023-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2176528, encodeId=a2de21e652869, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：投稿到接收6个月一共6个编辑 2个接收 4个给了小修意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56409118645, createdName=ms4000001399005501, createdTime=Fri Dec 22 13:59:13 CST 2023, time=2023-12-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2175766, encodeId=4b6021e57663e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：您好！ 请加一下**，复旦大学工作，希望和您深入沟通，谢谢您！ 17768300857, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd5a9105529, createdName=ms9000001835062032, createdTime=Tue Dec 19 10:43:11 CST 2023, time=2023-12-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2174747, encodeId=a33621e4747f9, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：23.05.23投稿 23.08.21两个审稿人接收 23.09.16大修 23.09.29修改后投稿 23.10.12一个审稿人同意发表，另一个审稿人要求小修 23.10.25二修后再投 23.11.07accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=550b8770319, createdName=ms8000001177361067, createdTime=Wed Dec 13 16:06:30 CST 2023, time=2023-12-13, status=1, ipAttribution=重庆)]

2023-12-20 Good luck3604 来自河北省

editor invited 到底要多久呢？

28 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2180350, encodeId=2c3c2180350d7, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：1 Reviewer report received 4个月了有没有大佬知道邮箱是多少想催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78df8786027, createdName=ms9000000778917018, createdTime=Tue Jan 09 21:07:33 CST 2024, time=2024-01-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2179786, encodeId=39de21e9786b5, content=👍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99f91357734, createdName=connie19860928, createdTime=Sun Jan 07 12:06:10 CST 2024, time=2024-01-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178835, encodeId=7a4321e883536, content=医学生信类这刊送外审了，被拒率高吗，有没有大佬了解的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:32:31 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2136242, encodeId=ff8f213624228, content=之前状态有过2 reviewers accepted，10天后变成1 reviewer report received状态后，现在已经持续快一个月了，有没有大佬知道后续还要等多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e41e8578522, createdName=ms2000000826223232, createdTime=Wed May 17 00:23:11 CST 2023, time=2023-05-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2122705, encodeId=69722122e051a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：药理学 经验分享：12月20号初投 12月28号修改格式再投 12月29号外审 1月23号意见返回小修 2月2号修回 2月7号二审 3月27号发了邮件催了一下28号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5196569930, createdName=ms4000001456586006, createdTime=Thu Mar 30 12:35:58 CST 2023, time=2023-03-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2167125, encodeId=1569216e12553, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：大神们啊，我的修改提交后收到一份修改意见后，就一直不动了，已经一个多月了，应该怎么办啊，是不是被遗忘了啊，家人们求解啊，该怎么办好啊，在线等哦 Peer review 1 Reviewer report received 05 Oct 23 Submission under peer review 19 Sep 2023 Submission passed technical check 19 Sep 2023 Revision received 17 Sep 2023 Submission under peer review 31 May 2023 Technical check Submission status Date Submission passed technical check 31 May 2023 Amendment received 22 May 2023 Amendment received 17 May 2023 Submission is under technical check 12 May 2023 Submission received Submission status Date Submission received 12 May 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a358285446, createdName=ms6000002137455091, createdTime=Tue Nov 07 00:30:06 CST 2023, time=2023-11-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176057, encodeId=9bad21e60571f, content=editor invited 到底要多久呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a73b2470790, createdName=Good luck3604, createdTime=Wed Dec 20 10:27:08 CST 2023, time=2023-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2176528, encodeId=a2de21e652869, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：投稿到接收6个月一共6个编辑 2个接收 4个给了小修意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56409118645, createdName=ms4000001399005501, createdTime=Fri Dec 22 13:59:13 CST 2023, time=2023-12-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2175766, encodeId=4b6021e57663e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：您好！ 请加一下**，复旦大学工作，希望和您深入沟通，谢谢您！ 17768300857, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd5a9105529, createdName=ms9000001835062032, createdTime=Tue Dec 19 10:43:11 CST 2023, time=2023-12-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2174747, encodeId=a33621e4747f9, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：23.05.23投稿 23.08.21两个审稿人接收 23.09.16大修 23.09.29修改后投稿 23.10.12一个审稿人同意发表，另一个审稿人要求小修 23.10.25二修后再投 23.11.07accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=550b8770319, createdName=ms8000001177361067, createdTime=Wed Dec 13 16:06:30 CST 2023, time=2023-12-13, status=1, ipAttribution=重庆)]

2023-12-22 ms4000001399005501 来自新疆

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤
经验分享：投稿到接收6个月一共6个编辑 2个接收 4个给了小修意见

22 0

[GetPortalCommentsPageByObjectIdResponse(id=2180350, encodeId=2c3c2180350d7, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：1 Reviewer report received 4个月了有没有大佬知道邮箱是多少想催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78df8786027, createdName=ms9000000778917018, createdTime=Tue Jan 09 21:07:33 CST 2024, time=2024-01-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2179786, encodeId=39de21e9786b5, content=👍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99f91357734, createdName=connie19860928, createdTime=Sun Jan 07 12:06:10 CST 2024, time=2024-01-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178835, encodeId=7a4321e883536, content=医学生信类这刊送外审了，被拒率高吗，有没有大佬了解的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:32:31 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2136242, encodeId=ff8f213624228, content=之前状态有过2 reviewers accepted，10天后变成1 reviewer report received状态后，现在已经持续快一个月了，有没有大佬知道后续还要等多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e41e8578522, createdName=ms2000000826223232, createdTime=Wed May 17 00:23:11 CST 2023, time=2023-05-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2122705, encodeId=69722122e051a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：药理学 经验分享：12月20号初投 12月28号修改格式再投 12月29号外审 1月23号意见返回小修 2月2号修回 2月7号二审 3月27号发了邮件催了一下28号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5196569930, createdName=ms4000001456586006, createdTime=Thu Mar 30 12:35:58 CST 2023, time=2023-03-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2167125, encodeId=1569216e12553, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：大神们啊，我的修改提交后收到一份修改意见后，就一直不动了，已经一个多月了，应该怎么办啊，是不是被遗忘了啊，家人们求解啊，该怎么办好啊，在线等哦 Peer review 1 Reviewer report received 05 Oct 23 Submission under peer review 19 Sep 2023 Submission passed technical check 19 Sep 2023 Revision received 17 Sep 2023 Submission under peer review 31 May 2023 Technical check Submission status Date Submission passed technical check 31 May 2023 Amendment received 22 May 2023 Amendment received 17 May 2023 Submission is under technical check 12 May 2023 Submission received Submission status Date Submission received 12 May 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a358285446, createdName=ms6000002137455091, createdTime=Tue Nov 07 00:30:06 CST 2023, time=2023-11-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176057, encodeId=9bad21e60571f, content=editor invited 到底要多久呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a73b2470790, createdName=Good luck3604, createdTime=Wed Dec 20 10:27:08 CST 2023, time=2023-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2176528, encodeId=a2de21e652869, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：投稿到接收6个月一共6个编辑 2个接收 4个给了小修意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56409118645, createdName=ms4000001399005501, createdTime=Fri Dec 22 13:59:13 CST 2023, time=2023-12-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2175766, encodeId=4b6021e57663e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：您好！ 请加一下**，复旦大学工作，希望和您深入沟通，谢谢您！ 17768300857, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd5a9105529, createdName=ms9000001835062032, createdTime=Tue Dec 19 10:43:11 CST 2023, time=2023-12-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2174747, encodeId=a33621e4747f9, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：23.05.23投稿 23.08.21两个审稿人接收 23.09.16大修 23.09.29修改后投稿 23.10.12一个审稿人同意发表，另一个审稿人要求小修 23.10.25二修后再投 23.11.07accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=550b8770319, createdName=ms8000001177361067, createdTime=Wed Dec 13 16:06:30 CST 2023, time=2023-12-13, status=1, ipAttribution=重庆)]

2023-12-19 ms9000001835062032 来自江苏省

审稿速度:2.0 | 投稿命中率:50.0
经验分享：您好！
请加一下**，复旦大学工作，希望和您深入沟通，谢谢您！
17768300857

28 0

[GetPortalCommentsPageByObjectIdResponse(id=2180350, encodeId=2c3c2180350d7, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：1 Reviewer report received 4个月了有没有大佬知道邮箱是多少想催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78df8786027, createdName=ms9000000778917018, createdTime=Tue Jan 09 21:07:33 CST 2024, time=2024-01-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2179786, encodeId=39de21e9786b5, content=👍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99f91357734, createdName=connie19860928, createdTime=Sun Jan 07 12:06:10 CST 2024, time=2024-01-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178835, encodeId=7a4321e883536, content=医学生信类这刊送外审了，被拒率高吗，有没有大佬了解的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:32:31 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2136242, encodeId=ff8f213624228, content=之前状态有过2 reviewers accepted，10天后变成1 reviewer report received状态后，现在已经持续快一个月了，有没有大佬知道后续还要等多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e41e8578522, createdName=ms2000000826223232, createdTime=Wed May 17 00:23:11 CST 2023, time=2023-05-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2122705, encodeId=69722122e051a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：药理学 经验分享：12月20号初投 12月28号修改格式再投 12月29号外审 1月23号意见返回小修 2月2号修回 2月7号二审 3月27号发了邮件催了一下28号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5196569930, createdName=ms4000001456586006, createdTime=Thu Mar 30 12:35:58 CST 2023, time=2023-03-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2167125, encodeId=1569216e12553, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：大神们啊，我的修改提交后收到一份修改意见后，就一直不动了，已经一个多月了，应该怎么办啊，是不是被遗忘了啊，家人们求解啊，该怎么办好啊，在线等哦 Peer review 1 Reviewer report received 05 Oct 23 Submission under peer review 19 Sep 2023 Submission passed technical check 19 Sep 2023 Revision received 17 Sep 2023 Submission under peer review 31 May 2023 Technical check Submission status Date Submission passed technical check 31 May 2023 Amendment received 22 May 2023 Amendment received 17 May 2023 Submission is under technical check 12 May 2023 Submission received Submission status Date Submission received 12 May 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a358285446, createdName=ms6000002137455091, createdTime=Tue Nov 07 00:30:06 CST 2023, time=2023-11-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176057, encodeId=9bad21e60571f, content=editor invited 到底要多久呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a73b2470790, createdName=Good luck3604, createdTime=Wed Dec 20 10:27:08 CST 2023, time=2023-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2176528, encodeId=a2de21e652869, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：投稿到接收6个月一共6个编辑 2个接收 4个给了小修意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56409118645, createdName=ms4000001399005501, createdTime=Fri Dec 22 13:59:13 CST 2023, time=2023-12-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2175766, encodeId=4b6021e57663e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：您好！ 请加一下**，复旦大学工作，希望和您深入沟通，谢谢您！ 17768300857, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd5a9105529, createdName=ms9000001835062032, createdTime=Tue Dec 19 10:43:11 CST 2023, time=2023-12-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2174747, encodeId=a33621e4747f9, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：23.05.23投稿 23.08.21两个审稿人接收 23.09.16大修 23.09.29修改后投稿 23.10.12一个审稿人同意发表，另一个审稿人要求小修 23.10.25二修后再投 23.11.07accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=550b8770319, createdName=ms8000001177361067, createdTime=Wed Dec 13 16:06:30 CST 2023, time=2023-12-13, status=1, ipAttribution=重庆)]

2023-12-13 ms8000001177361067 来自重庆

审稿速度:6.0 | 投稿命中率:75.0
经验分享：23.05.23投稿
23.08.21两个审稿人接收
23.09.16大修
23.09.29修改后投稿
23.10.12一个审稿人同意发表，另一个审稿人要求小修
23.10.25二修后再投
23.11.07accept

74 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务